Novabay Pharmaceuticals Stock Price on February 28, 2024
| NBY Stock | USD 0.57 0.01 2.66% |
Below is the normalized historical share price chart for NovaBay Pharmaceuticals extending back to October 26, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NovaBay Pharmaceuticals stands at 0.57, as last reported on the 13th of December 2024, with the highest price reaching 0.58 and the lowest price hitting 0.55 during the day.
If you're considering investing in NovaBay Stock, it is important to understand the factors that can impact its price. NovaBay Pharmaceuticals appears to be dangerous, given 3 months investment horizon. NovaBay Pharmaceuticals has Sharpe Ratio of 0.0593, which conveys that the firm had a 0.0593% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for NovaBay Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise NovaBay Pharmaceuticals' Risk Adjusted Performance of 0.0545, mean deviation of 4.28, and Downside Deviation of 4.4 to check out if our risk estimates are consistent with your expectations.
At this time, NovaBay Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 125.5 K in 2024, whereas Other Stockholder Equity is likely to drop slightly above 88.1 M in 2024. . Price Earnings To Growth Ratio is likely to rise to 0 in 2024, whereas Price To Sales Ratio is likely to drop 0.06 in 2024. NovaBay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of October 2007 | 200 Day MA 2.0128 | 50 Day MA 0.652 | Beta 0.732 |
NovaBay |
Sharpe Ratio = 0.0593
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NBY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.79 actual daily | 69 69% of assets are less volatile |
Expected Return
| 0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average NovaBay Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NovaBay Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 2.4516 | Enterprise Value Ebitda (0.34) | Price Sales 0.2086 | Shares Float 4.9 M | Wall Street Target Price 3.725 |
Related Headline
AVROBIO Headline on 28th of February 2024
SHAREHOLDER UPDATE Halper Sadeh LLC Investigates AXNX, KAMN,... by benzinga.com
NEW YORK, Feb. 28, 2024 -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws andor breaches of fiduciary
NovaBay Pharmaceuticals Valuation on February 28, 2024
It is possible to determine the worth of NovaBay Pharmaceuticals on a given historical date. On February 28, 2024 NovaBay was worth 5.01 at the beginning of the trading date compared to the closed value of 5.39. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NovaBay Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find NovaBay Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NovaBay Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NovaBay Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 5.25 | 5.25 | 4.90 | 4.98 | 47,335 | |
02/28/2024 | 5.01 | 5.59 | 4.94 | 5.39 | 51,765 |
| 5.40 | 5.40 | 5.05 | 5.11 | 38,599 |
| Backtest NovaBay Pharmaceuticals | | | NovaBay Pharmaceuticals History | | | NovaBay Pharmaceuticals Valuation | Previous | Next |
NovaBay Pharmaceuticals Trading Date Momentum on February 28, 2024
| On February 29 2024 NovaBay Pharmaceuticals was traded for 5.11 at the closing time. Highest NovaBay Pharmaceuticals's price during the trading hours was 5.40 and the lowest price during the day was 5.05 . The net volume was 38.6 K. The overall trading history on the 29th of February contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 5.19% . The trading delta at closing time to current price is 7.61% . |
NovaBay Pharmaceuticals Fundamentals Correlations and Trends
By evaluating NovaBay Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among NovaBay Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. NovaBay financial account trend analysis is a perfect complement when working with valuation or volatility modules.About NovaBay Pharmaceuticals Stock history
NovaBay Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NovaBay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NovaBay Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NovaBay Pharmaceuticals stock prices may prove useful in developing a viable investing in NovaBay Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 120.4 K | 125.5 K | |
| Net Loss | -14.6 M | -15.4 M |
NovaBay Pharmaceuticals Stock Technical Analysis
NovaBay Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NovaBay Pharmaceuticals Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
NovaBay Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NovaBay Pharmaceuticals December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how NovaBay Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NovaBay Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying NovaBay Pharmaceuticals stock market strength indicators, traders can identify NovaBay Pharmaceuticals entry and exit signals to maximize returns
NovaBay Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NovaBay Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of NovaBay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NovaBay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0545 | |||
| Jensen Alpha | 0.5966 | |||
| Total Risk Alpha | (0.61) | |||
| Sortino Ratio | 0.0839 | |||
| Treynor Ratio | (0.38) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for NovaBay Stock Analysis
When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.